Where do things stand with some players in the for-profit world of stem cell and cellular medicine companies? Here are a few brief news items with quick analysis. Mesoblast is dominating the news of late. Mesoblast reported good news from its Phase II safety trial for its mesenchymal progenitor cell (MPC) product in patients with […]
Stem Cell & Cell Med Industry Briefs Read More »
What’s the deal with this week’s FDA Warning Letter to 23andMe? First some background. I’m a researcher who studies stem and cancer cell genomics and epigenomics. I’m also a human being who has battled prostate cancer and is curious about my genome. With this background, I decided some time ago to take the plunge and experience what
23andMe and the FDA: Perspectives on Warning Letter Read More »
The World Alliance Forum held a really great meeting yesterday in SF about the future of stem cells. Below, Johnathon Anderson has a great guest post summarizing the meeting. The collective brain power in the room was pretty staggering. The meeting brought together stem cell leaders from academia, industry, startup incubators and funding agencies. The purpose
Guest Post on the Future of Stem Cells: World Alliance Forum Meeting Read More »
I recently held a flash 48 hour contest for free tickets to the World Alliance Forum on the future of stem cells at which Yamanaka and others will be speaking. Congrats to the winners, Sai Vemula and Johnathon Anderson. Here are their winning entries. Sai Vemula Editor, SSSCR-International, UC Berkeley, Molecular and Cell Biology B.A. This
You can jailbreak your iPhone, but perhaps you can jailbreak a cell too to turn it into a stem cell. In his very cool talk up here at the Till & McCulloch Meeting on Stem Cells yesterday, Andras Nagy characterized the reprogramming process to make iPS cells as “jailbreaking” cell fate. Nagy described some intriguing studies done on
Jailbreak Cell Fate to Reprogram Stem Cells Read More »
When Jacob Hanna says “radically deterministic” cellular reprogramming, what does he mean? Jacob Hanna’s lab recently published a very high profile Nature paper on nearly 100% efficient iPS cell formation based on targeting a factor called Mbd3. This super efficiency is a major departure from past reported efficiencies. This morning here at the Till &
Jacob Hanna on Radically Deterministic Reprogramming @TMM2013 Read More »
BioTime (BTX), via its subsidiary Asterias, has formally purchased the Geron (GERN) embryonic stem cell (ESC) research program and assets. Incidentally, Asterias in nature refers to a genus of sea stars including starfish and you can see it in their logo. Perhaps this was chosen given the amazing regenerative capacity of starfish? You may recall
Great news: BioTime Subsidiary Asterias Acquires Geron Embryonic Stem Cell Program Read More »
Here is a comprehensive listing of the top stem cell meetings and conferences for 2014. My listing of these meetings is not an endorsement of them, but is provided for informational purposes so I am being as inclusive as possible. If you want me to post your meeting, email me or post a comment (I’ll delete
Stem Cell Meetings & Conferences 2014 Read More »
What if you could reprogram cells inside of an organism to a different fate and, for instance, make IPS cells? We can, right? But when most of us think about making induced pluripotent stem (iPS) cells, we imagine it all happening in a little plastic dish in our labs or in our colleague’s labs, not
Stem cell journal club: dishing on Nature paper on making iPS cells inside mice Read More »
¿Qué son las células madre? What does this mean? What are stem cells is ‘¿Qué son las células madre?’ in Spanish (2024 update: note that this post is part of our stem cells not lost in translation project: please see here for 34 other languages. This post also addresses another common question, “what are stem
¿Qué son las células madre? Read More »